Explosive type of moderate-resistance training induces functional, cardiovascular, and molecular adaptations in the elderly

Current recommendations aimed at reducing neuromuscular and functional loss in aged muscle have identified muscle power as a key target for intervention trials, although little is known about the biological and cardiovascular systemic response in the elderly. This study investigated the effects of 1...

Full description

Saved in:
Bibliographic Details
Published inAGE Vol. 36; no. 2; pp. 759 - 772
Main Authors Beltran Valls, Maria Reyes, Dimauro, Ivan, Brunelli, Andrea, Tranchita, Eliana, Ciminelli, Emanuela, Caserotti, Paolo, Duranti, Guglielmo, Sabatini, Stefania, Parisi, Paolo, Parisi, Attilio, Caporossi, Daniela
Format Journal Article
LanguageEnglish
Published Dordrecht Springer Netherlands 01.04.2014
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Current recommendations aimed at reducing neuromuscular and functional loss in aged muscle have identified muscle power as a key target for intervention trials, although little is known about the biological and cardiovascular systemic response in the elderly. This study investigated the effects of 12 weeks of low-frequency, moderate-intensity, explosive-type resistance training (EMRT) on muscle strength and power in old community-dwelling people (70–75 years), monitoring functional performance linked to daily living activities (ADL) and cardiovascular response, as well as biomarkers of muscle damage, cardiovascular risk, and cellular stress response. The present study provides the first evidence that EMRT was highly effective in achieving a significant enhancement in muscular strength and power as well as in functional performance without causing any detrimental modification in cardiovascular, inflammatory, and damage parameters. Moreover, trained elderly subjects showed an adaptive response at both systemic and cellular levels by modulation of antioxidant and stress-induced markers such as myeloperoxidase (MPO), heat shock protein 70 (Hsp70) and 27 (Hsp27), and thioredoxin reductase 1 (TrxR1).
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
ISSN:0161-9152
2509-2715
1574-4647
1574-4647
2509-2723
DOI:10.1007/s11357-013-9584-1